From April 3–6, 2025, Kallisio, in collaboration with RICOH 3D for Healthcare, exhibited stentra™, its patient-specific oral stent for head and neck cancer radiotherapy, at the 107th Annual Meeting of the American Radium Society (ARS)held at the Grand Hyatt in Seattle.

The ARS congress is a prestigious multidisciplinary event that brings together radiation oncologists, surgeons, radiologists, and cancer researchers to share the latest innovations in cancer care. At the event, the Kallisio and RICOH teams demonstrated how Stentra™ enhances the precision of radiation therapy by immobilizing the tongue and jaw, thereby sparing healthy tissue from exposure.

Stentra™ is FDA 510(k)-cleared and manufactured in collaboration with RICOH using a network of medical-grade 3D printing facilities. Attendees had the opportunity to explore the streamlined scan-to-stent workflow, which enables design, production, and shipment within just 72 hours via a secure clinical portal that meets HIPAA and GDPR standards.